14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs to treat cancer and autoimmune diseases to reign in rising public healthcare costs.

“Where there is a more affordable alternative at the same quality, we have to use it,” Spahn, who is vying to succeed German Chancellor Angela Merkel as leader of the center-right Christian Democrat party, told daily Handelsblatt.

“Otherwise we won’t be able to sustain the high quality of pharmaceutical supply in Germany,” he said in the interview published on Wednesday.

Read Reuters article